AMT-562, a Novel HER3-targeting Antibody–Drug Conjugate, Demonstrates a Potential to Broaden Therapeutic Opportunities for HER3-expressing TumorsWeining Weng, Xun Meng|Molecular Cancer Therapeutics|2023Cited by 24